Issue
Effect of Triptolide on retinal ganglion cell survival in an optic nerve crush model
Corresponding Author(s) : W. Zhang
Cellular and Molecular Biology,
Vol. 63 No. 5: Issue 5
Abstract
Optic nerve crush model could be used to investigate the mechanism of neuronal survival and axonal regeneration in central nervous system. Triptolide, a Chinese herb extract with anti-inflammatory and immunosuppressive activities, has shown neuron protective functions in nervous system. In this study, we investigated the changes in retinal ganglion cell survival and axonal regeneration after administration of triptolide in optic nerve crush model. Triptolide treatment tended to promote retinal ganglion cell survival rather than optic nerve regeneration as well as inhibit the expression of tumor necrosis factor-α and activation of nuclear factor-kappa B. These findings suggested that intraperitoneal injection of triptolide may be an effective treatment for optic nerve injury and this effect was attributed at least in part to its anti-inflammatory actions.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- Park KK, Liu K, Hu Y, Kanter JL and He Z. PTEN/mTOR and axon regeneration. Exp Neurol 2010; 223: 45-50.
- Cregg JM, DePaul MA, Filous AR, Lang BT, Tran A and Silver J. Functional regeneration beyond the glial scar. Exp Neurol 2014; 253: 197-207.
- Schwab ME and Strittmatter SM. Nogo limits neural plasticity and recovery from injury. Curr Opin Neurobiol 2014; 27: 53-60.
- Templeton JP and Geisert EE. A practical approach to optic nerve crush in the mouse. Mol Vis 2012; 18: 2147-52.
- Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, et al., Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008; 322: 963-6.
- Smith PD, Sun F, Park KK, Cai B, Wang C, Kuwako K, et al., SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 2009; 64: 617-23.
- Sun F, Park KK, Belin S, Wang D, Lu T, Chen G, et al., Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 2011; 480: 372-75.
- Wang Y, Mei Y, Feng D and Xu L. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurosci Res 2008; 86: 2441-9.
- Liu J, Shen M, Yue Z, Yang Z, Wang M, Li C, et al., Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21. Phytomedicine 2012; 19: 756-62.
- Qiu D and Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 2003; 4: 1-18.
- Qiu D, Zhao G, Aoki Y, Shi L, Uyei A, Nazarian S, et al., Immunosuppressant PG490 (Triptolide) Inhibits T-cell Interleukin-2 Expression at the Level of Purine-box/Nuclear Factor of Activated T-cells and NF-κB Transcriptional Activation. Journal of Biological Chemistry 1999; 274: 13443-50.
- Shui G, Wan Y, Jiang C, Zhang H, Chen P, Wang C, et al., [Progress in Tripterygium wilfordiiand its bioactive components in the field of pharmacodynamics and pharmacology]. Zhongguo Zhong Yao Za Zhi 2010; 35: 515-20.
- Brinker AM, Ma J, Lipsky PE and Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 2007; 68: 732-66.
- Zhou HF, Niu DB, Xue B, Li FQ, Liu XY, He QH, et al., Triptolide inhibits TNF-alpha, IL-1 beta and NO production in primary microglial cultures. Neuroreport 2003; 14: 1091-5.
- Lu L, Li F and Wang X. Novel anti-inflammatory and neuroprotective agents for Parkinson's disease. CNS & neurological disorders drug targets 2010; 9: 232-40.
- Zhou HF, Liu XY, Niu DB, Li FQ, He QH and Wang XM. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiol Dis 2005; 18: 441-9.
- Xue B, Jiao J, Zhang L, Li KR, Gong YT, Xie JX, et al., Triptolide upregulates NGF synthesis in rat astrocyte cultures. Neurochem Res 2007; 32: 1113-9.
- Baskaya MK, Dogan A, Rao AM and Dempsey RJ. Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury. J Neurosurg 2000; 92: 448-52.
- Zhou H-F, Niu D-B, Xue B, Li F-Q, Liu X-Y, He Q-H, et al., Triptolide inhibits TNF"α, IL"1β and NO production in primary microglial cultures. NeuroReport 2003; 14: 1091-95.
- Barnes PJ and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-71.
- Jin X-Q, Ye F, Zhang J-J, Zhao Y and Zhou X-L. Triptolide attenuates cerebral ischemia and reperfusion injury in rats through the inhibition the nuclear factor kappa B signaling pathway. Neuropsychiatric Disease and Treatment 2015; 11: 1395-403.
- Hu Y, Park KK, Yang L, Wei X, Yang Q, Cho KS, et al., Differential effects of unfolded protein response pathways on axon injury-induced death of retinal ganglion cells. Neuron 2012; 73: 445-52.
- Leon S, Yin Y, Nguyen J, Irwin N and Benowitz LI. Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci 2000; 20: 4615-26.
- Park K, Luo J-M, Hisheh S, Harvey AR and Cui Q. Cellular Mechanisms Associated with Spontaneous and Ciliary Neurotrophic Factor-cAMP-Induced Survival and Axonal Regeneration of Adult Retinal Ganglion Cells. The Journal of Neuroscience 2004; 24: 10806.
- Botchkina GI, Meistrell ME, 3rd, Botchkina IL and Tracey KJ. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 1997; 3: 765-81.
- Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, et al., Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994; 25: 1481-8.
- Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, et al., CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999; 19: 3809-17.
- Rothwell NJ and Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1995; 18: 130-6.
- Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. American Journal of Physiology - Cell Physiology 1992; 263: C1.
- Madigan MC, Sadun AA, Rao NS, Dugel PU, Tenhula WN and Gill PS. Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res 1996; 18: 176-84.
- Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, et al., Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab 2005; 25: 30-40.
- Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T and Schwaninger M. NF-[kappa]B is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999; 5: 554-59.
References
Park KK, Liu K, Hu Y, Kanter JL and He Z. PTEN/mTOR and axon regeneration. Exp Neurol 2010; 223: 45-50.
Cregg JM, DePaul MA, Filous AR, Lang BT, Tran A and Silver J. Functional regeneration beyond the glial scar. Exp Neurol 2014; 253: 197-207.
Schwab ME and Strittmatter SM. Nogo limits neural plasticity and recovery from injury. Curr Opin Neurobiol 2014; 27: 53-60.
Templeton JP and Geisert EE. A practical approach to optic nerve crush in the mouse. Mol Vis 2012; 18: 2147-52.
Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, et al., Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008; 322: 963-6.
Smith PD, Sun F, Park KK, Cai B, Wang C, Kuwako K, et al., SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 2009; 64: 617-23.
Sun F, Park KK, Belin S, Wang D, Lu T, Chen G, et al., Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 2011; 480: 372-75.
Wang Y, Mei Y, Feng D and Xu L. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurosci Res 2008; 86: 2441-9.
Liu J, Shen M, Yue Z, Yang Z, Wang M, Li C, et al., Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21. Phytomedicine 2012; 19: 756-62.
Qiu D and Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 2003; 4: 1-18.
Qiu D, Zhao G, Aoki Y, Shi L, Uyei A, Nazarian S, et al., Immunosuppressant PG490 (Triptolide) Inhibits T-cell Interleukin-2 Expression at the Level of Purine-box/Nuclear Factor of Activated T-cells and NF-κB Transcriptional Activation. Journal of Biological Chemistry 1999; 274: 13443-50.
Shui G, Wan Y, Jiang C, Zhang H, Chen P, Wang C, et al., [Progress in Tripterygium wilfordiiand its bioactive components in the field of pharmacodynamics and pharmacology]. Zhongguo Zhong Yao Za Zhi 2010; 35: 515-20.
Brinker AM, Ma J, Lipsky PE and Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 2007; 68: 732-66.
Zhou HF, Niu DB, Xue B, Li FQ, Liu XY, He QH, et al., Triptolide inhibits TNF-alpha, IL-1 beta and NO production in primary microglial cultures. Neuroreport 2003; 14: 1091-5.
Lu L, Li F and Wang X. Novel anti-inflammatory and neuroprotective agents for Parkinson's disease. CNS & neurological disorders drug targets 2010; 9: 232-40.
Zhou HF, Liu XY, Niu DB, Li FQ, He QH and Wang XM. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiol Dis 2005; 18: 441-9.
Xue B, Jiao J, Zhang L, Li KR, Gong YT, Xie JX, et al., Triptolide upregulates NGF synthesis in rat astrocyte cultures. Neurochem Res 2007; 32: 1113-9.
Baskaya MK, Dogan A, Rao AM and Dempsey RJ. Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury. J Neurosurg 2000; 92: 448-52.
Zhou H-F, Niu D-B, Xue B, Li F-Q, Liu X-Y, He Q-H, et al., Triptolide inhibits TNF"α, IL"1β and NO production in primary microglial cultures. NeuroReport 2003; 14: 1091-95.
Barnes PJ and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-71.
Jin X-Q, Ye F, Zhang J-J, Zhao Y and Zhou X-L. Triptolide attenuates cerebral ischemia and reperfusion injury in rats through the inhibition the nuclear factor kappa B signaling pathway. Neuropsychiatric Disease and Treatment 2015; 11: 1395-403.
Hu Y, Park KK, Yang L, Wei X, Yang Q, Cho KS, et al., Differential effects of unfolded protein response pathways on axon injury-induced death of retinal ganglion cells. Neuron 2012; 73: 445-52.
Leon S, Yin Y, Nguyen J, Irwin N and Benowitz LI. Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci 2000; 20: 4615-26.
Park K, Luo J-M, Hisheh S, Harvey AR and Cui Q. Cellular Mechanisms Associated with Spontaneous and Ciliary Neurotrophic Factor-cAMP-Induced Survival and Axonal Regeneration of Adult Retinal Ganglion Cells. The Journal of Neuroscience 2004; 24: 10806.
Botchkina GI, Meistrell ME, 3rd, Botchkina IL and Tracey KJ. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 1997; 3: 765-81.
Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, et al., Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994; 25: 1481-8.
Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, et al., CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999; 19: 3809-17.
Rothwell NJ and Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1995; 18: 130-6.
Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. American Journal of Physiology - Cell Physiology 1992; 263: C1.
Madigan MC, Sadun AA, Rao NS, Dugel PU, Tenhula WN and Gill PS. Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res 1996; 18: 176-84.
Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, et al., Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab 2005; 25: 30-40.
Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T and Schwaninger M. NF-[kappa]B is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999; 5: 554-59.